NEO

Neogenomics
$13.14
−$0.75 (−5.4%)Jul 27, 2026
8.1GreatMoatMint rating

MoatMint rates Neogenomics (NEO) 8.1 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 5.1 out of 10.

Key metrics

The numbers that frame NEO today
Market cap
$1.71B
P/E (TTM)
-17.2
EV / FCF
-387.8
Gross margin
43.2%
EV / Sales
2.6
ROIC
-13.9%
Div yield
0%
Debt / equity
0.5
52wk Low
$4.72
52wk High
$15.57

NEO stock rating

How NEO scores on quality, value, growth, momentum and financial health
8.1out of 10
Great overallHealthy business, full priceTop 19% of ~5,000 US stocks
QualityNeutral5.1/10
GrowthGood7.8/10
MomentumGreat9.1/10
ValueFair3.6/10
Financial HealthGreat8.4/10

Growth

Revenue and earnings trend for NEO
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about NEO
Is Neogenomics a good buy?
Yes. Neogenomics has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Neogenomics is selling at a high price, which cuts against the buy case.
What is the market capitalization of NEO?
Neogenomics's market capitalization is $1.71B.
What is the P/E ratio for NEO stock?
Neogenomics's current P/E ratio is -17.2.
What is the 52-week high for NEO stock?
The 52-week high for Neogenomics is $15.57. The current close of $13.14 is 15.6% below that high.
What is the 52-week low for NEO stock?
The 52-week low for Neogenomics is $4.72. The current close of $13.14 is 178.4% above that low.
Does NEO stock pay dividends?
Neogenomics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NEO?
Neogenomics's Debt / Equity ratio is 0.49.